For instance, activation of the C-terminal transactivation domain of HIF-1α promotes AKI-to-CKD progression via the KLF5 signaling pathway, a process that can be significantly blocked by the HIF-1α inhibitor PX-478 (Li et al., 2021a). The gene discussed is HIF1A; the disease is chronic kidney disease.